Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: Twelve-month outcomes of a phase III study

Peter A. Campochiaro, David M. Brown, Carl C. Awh, S. Young Lee, Sarah Gray, Namrata Saroj, Wendy Yee Murahashi, Roman G. Rubio

Research output: Contribution to journal › Article › peer-review

496 Scopus citations

Fingerprint

Dive into the research topics of 'Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: Twelve-month outcomes of a phase III study'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases